Beyond the cellular function, we aimed to assess a possible influence of PAF-AH on the Wnt signaling pathway for a better understanding of ovarian cancer pathophysiology, taking into account differences between BRCA1 mutation carriers and BRCA wildtype (WT) patients. The gene discussed is BRCA1; the disease is ovarian carcinoma.